Suu Saa Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 30-12-2024
- Paid Up Capital ₹ 2.90 M
as on 30-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.40 M
as on 30-12-2024
- Revenue -74.78%
(FY 2022)
- Profit -84.59%
(FY 2022)
- Ebitda 133.65%
(FY 2022)
- Net Worth 0.81%
(FY 2022)
- Total Assets 0.96%
(FY 2022)
About Suu Saa Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.90 M.
The company currently has active open charges totaling ₹0.40 M.
Subhash Bajaj, Sanjeev Nayyar, and Saurabh Nayyar serve as directors at the Company.
- CIN/LLPIN
U55101DL2006PTC151270
- Company No.
151270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Suu Saa Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Bajaj  | Director | 26-Jul-2006 | Current |
| Sanjeev Nayyar | Director | 26-Jul-2006 | Current |
| Saurabh Nayyar | Director | 30-Aug-2018 | Current |
Financial Performance of Suu Saa Biotech.
Suu Saa Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 74.78% decrease. The company also saw a substantial fall in profitability, with a 84.59% decrease in profit. The company's net worth moved up by a moderate rise of 0.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suu Saa Biotech?
In 2020, Suu Saa Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nayyar Overseas Private LimitedActive 31 years 11 monthsSanjeev Nayyar and Saurabh Nayyar are mutual person
Charges (Loans)
₹0.40 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2011 | Punjab National Bank | ₹0.40 M | Open |
How Many Employees Work at Suu Saa Biotech?
Unlock and access historical data on people associated with Suu Saa Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suu Saa Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suu Saa Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.